Innoviva
INVA
#5385
Rank
โ‚น153.83 B
Marketcap
โ‚น2,084
Share price
1.41%
Change (1 day)
23.79%
Change (1 year)

Revenue for Innoviva (INVA)

Revenue in 2026 (TTM): โ‚น37.62 Billion

According to Innoviva's latest financial reports the company's current revenue (TTM ) is โ‚น40.63 Billion. In 2025 the company made a revenue of โ‚น36.92 Billion an increase over the revenue in the year 2024 that were of โ‚น30.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innoviva from 2005 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น37.62 B1.89%
2025 โ‚น36.92 B19.99%
2024 โ‚น30.77 B19.06%
2023 โ‚น25.84 B-5.74%
2022 โ‚น27.41 B-6%
2021 โ‚น29.16 B18.42%
2020 โ‚น24.63 B32.33%
2019 โ‚น18.61 B1.99%
2018 โ‚น18.25 B31.58%
2017 โ‚น13.86 B52.8%
2016 โ‚น9.07 B153.17%
2015 โ‚น3.58 B570.8%
2014 โ‚น0.53 B82.94%
2013 โ‚น0.29 B-96.07%
2012 โ‚น7.43 B473.22%
2011 โ‚น1.29 B19.47%
2010 โ‚น1.08 B-4.03%
2009 โ‚น1.13 B1.88%
2008 โ‚น1.11 B28.56%
2007 โ‚น0.86 B-0.47%
2006 โ‚น0.86 B59.93%
2005 โ‚น0.54 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น56.12 B 38.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.82 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA